Summary of Study ST003145

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001956. The data can be accessed directly via it's Project DOI: 10.21228/M8WF0F This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003145
Study TitleMuscle-type specific stress responses explain the onset of external ophthalmoplegia in mitochondrial disease
Study SummaryMitochondrial dysfunctions elicit progressive tissue-specific stress responses that can be protective or deleterious. Here, we show that even different muscles of an individual react differently to mitochondrial disease. In mitochondrial myopathy (MM), the extraocular muscles (EOMs) are affected first, followed by exercise intolerance in the large lower limb muscles. Both muscle types show clear signs of respiratory chain deficiency. However, the limbs upregulate the mitochondrial integrated stress response (ISRmt) that drives glucose carbons to anabolic repair pathways, while EOMs present no signs of ISRmt. In contrast, in EOMs, Pdk4 activation inhibits pyruvate metabolism, while beta-oxidation of fatty acids is induced - despite the reliance of beta-oxidation on a functional respiratory chain for ATP production. The data suggest that the inability to upregulate ISRmt and consequent deleterious fuel choices sensitize EOMs to early weakness and atrophy, explaining ophthalmoplegia, the most common MM sign. The distinct responses to disease even in muscles of a single individual predict different responses to treatment, which is essential knowledge when designing interventions.
Institute
University of Helsinki
DepartmentFaculty of Medicine
LaboratoryAnu Wartiovaara Lab
Last NamePradhan
First NameSwagat
AddressC519b, Biomedicum 1, Haartmaninkatu 8, Helsinki
Emailswagat.pradhan@helsinki.fi
Phone+358465287359
Submit Date2024-02-21
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2025-01-02
Release Version1
Swagat Pradhan Swagat Pradhan
https://dx.doi.org/10.21228/M8WF0F
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001956
Project DOI:doi: 10.21228/M8WF0F
Project Title:Muscle-type specific stress responses explain external ophthalmoplegia in mitochondrial disease
Project Summary:Mitochondrial dysfunctions elicit progressive tissue-specific stress responses that can be protective or deleterious. Here, we show that even different muscles of an individual react differently to mitochondrial disease. In mitochondrial myopathy (MM), the extraocular muscles (EOMs) are affected first, followed by exercise intolerance in the large lower limb muscles. Both muscle types show clear signs of respiratory chain deficiency. However, the limbs upregulate the mitochondrial integrated stress response (ISRmt) that drives glucose carbons to anabolic repair pathways, while EOMs present no signs of ISRmt. In contrast, in EOMs, Pdk4 activation inhibits pyruvate metabolism, while beta-oxidation of fatty acids is induced - despite the reliance of beta-oxidation on a functional respiratory chain for ATP production. The data suggest that the inability to upregulate ISRmt and consequent deleterious fuel choices sensitize EOMs to early weakness and atrophy, explaining ophthalmoplegia, the most common MM sign. The distinct responses to disease even in muscles of a single individual predict different responses to treatment, which is essential knowledge when designing interventions.
Institute:University of Helsinki
Laboratory:Anu Wartiovaara Lab
Last Name:Pradhan
First Name:Swagat
Address:C519b, Biomedicum 1, Haartmaninkatu 8, Helsinki, Uusimaa, 00290, Finland
Email:swagat.pradhan@helsinki.fi
Phone:+358465287359

Subject:

Subject ID:SU003262
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
Species Group:Mammals

Factors:

Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)

mb_sample_id local_sample_id Sample source Genotype
SA340691Del_2_EOMExtra-ocular muscle Deletor
SA340692Del_3_EOMExtra-ocular muscle Deletor
SA340693Del_5_EOMExtra-ocular muscle Deletor
SA340694Del_1_EOMExtra-ocular muscle Deletor
SA340695Del_4_EOMExtra-ocular muscle Deletor
SA340696Del_6_EOMExtra-ocular muscle Deletor
SA340697WT_1_EOMExtra-ocular muscle Wild type
SA340698WT_7_EOMExtra-ocular muscle Wild type
SA340699WT_3_EOMExtra-ocular muscle Wild type
SA340700WT_2_EOMExtra-ocular muscle Wild type
SA340701WT_6_EOMExtra-ocular muscle Wild type
SA340702WT_5_EOMExtra-ocular muscle Wild type
SA340703WT_4_EOMExtra-ocular muscle Wild type
SA340704Del_1_QFQuadriceps femoris Deletor
SA340705Del_4_QFQuadriceps femoris Deletor
SA340706Del_3_QFQuadriceps femoris Deletor
SA340707Del_5_QFQuadriceps femoris Deletor
SA340708Del_2_QFQuadriceps femoris Deletor
SA340709Del_6_QFQuadriceps femoris Deletor
SA340710WT_4_QFQuadriceps femoris Wild type
SA340711WT_1_QFQuadriceps femoris Wild type
SA340712WT_2_QFQuadriceps femoris Wild type
SA340713WT_3_QFQuadriceps femoris Wild type
SA340714WT_5_QFQuadriceps femoris Wild type
SA340715WT_6_QFQuadriceps femoris Wild type
Showing results 1 to 25 of 25

Collection:

Collection ID:CO003255
Collection Summary:Muscles were extracted by excision and snap frozen in liquid nitrogen
Sample Type:Muscle

Treatment:

Treatment ID:TR003271
Treatment Summary:The experimental mouse model used in this study (Deletor) are transgenic for Twnk, encoding Twinkle, a nuclear-encoded mtDNA helicase that carries a dominant mutation (homologous to a MM patient mutation, leading into a 13-amino acid duplication of amino acids p.353-365 in the protein). The controls were wild-type (WT) littermates of Deletor mice. WT mice are used as controls. The genotype and tissue specific differences were studied by analysing metabolites from Quadriceps femoris(QF) and extra-ocular muscles(EOM).

Sample Preparation:

Sampleprep ID:SP003269
Sampleprep Summary:The samples were added to 2 ml Precellys homogenization tube (Bertin Technologies, Montigny-le-Bretonneux, France) with 2.8 mm ceramic (zirconium oxide) beads with 500µl of cold extraction solvent (Acetonitrile:Methanol:Milli-Q Water; 40:40:20). Subsequently, samples were homogenized using a tissue homogenizer (Bertin Technologies, France) for 3 cycles (30sec at 5500rpm with 60sec pause at 4°C). It was then followed by centrifugation at 14000rpm at 4°C for 5 minutes. The supernatant was then loaded into a Phenomenex, Phree Phospholipid removal 96 well plate 30mg (Part No. 8E-S133-TGB) and passed through using a robotic vacuum. The resulting filtrate was then transferred into polypropylene tubes and placed into a Nitrogen gas evaporator to completely dry the solvent.

Combined analysis:

Analysis ID AN005161
Analysis type MS
Chromatography type HILIC
Chromatography system Thermo Vanquish
Column Merck SeQuant ZIC-pHILIC (100 x 2.1mm,5um)
MS Type ESI
MS instrument type Orbitrap
MS instrument name Thermo Q Exactive Orbitrap
Ion Mode UNSPECIFIED
Units Peak intensity

Chromatography:

Chromatography ID:CH003906
Instrument Name:Thermo Vanquish
Column Name:Merck SeQuant ZIC-pHILIC (100 x 2.1mm,5um)
Column Temperature:40 ± 3
Flow Gradient:gradient elution began with 20% mobile phase A and 80% mobile phase B and was maintained until 2 minutes. Then, mobile phase A was gradually increased from 20% to 80% until 17 minutes, followed by a decrease from 80% to 20% in mobile phase A from 17.1 minutes and maintained up to 24 minutes.
Flow Rate:0.100 mL/minute
Solvent A:100% water, 20mM Ammonium hydrogen carbonate, pH 9.4
Solvent B:100% acetonitrile
Chromatography Type:HILIC

MS:

MS ID:MS004897
Analysis ID:AN005161
Instrument Name:Thermo Q Exactive Orbitrap
Instrument Type:Orbitrap
MS Type:ESI
MS Comments:Mass spectrometry (MS) was used with a heated electrospray ionization (H-ESI) source using polarity switching and the following settings: resolution of 70,000, spray voltages of 4250 V for positive mode and 3250 V for negative mode, sheath gas flow rate of 25 arbitrary units (AU), auxiliary gas flow rate of 15 AU, sweep gas flow rate of 0, capillary temperature of 275°C, and S-lens RF level of 50.0. The instrument was controlled with the Xcalibur 4.1.31.9 software (Thermo Fischer Scientific, Waltham, MA, USA). In data processing, peak integration was performed using TraceFinder 5.1 software (Thermo Fischer Scientific), and the confirmed retention times of 462 metabolites in an in-house library developed using the library kit MSMLS-1EA (Merck) were used. The peak area data were exported as an excel file for further analysis. Data quality was monitored throughout the run using a pooled sample as Quality Control (QC), which was prepared by pooling 5µL from each suspended sample and interspersed throughout the run as every 10th sample. After integration of QC data with TraceFinder 5.1, detected metabolites were checked for peak, and % RSD were calculated. An acceptance limit was set at ≤20%. Blank samples for carryover were injected after every fifth randomized sample to monitor the metabolites' carryover effect and were calculated against the mean QC area. The acceptance limit was set at ≤20% for each metabolite. Background % noise was calculated with respect to the first blank against the mean QC area, and the acceptance limit was set at ≤20% for each metabolite.
Ion Mode:UNSPECIFIED
  logo